Skip to main content
Clinical Trials/NCT07463391
NCT07463391Not yet recruitingNot Applicable

The Effect of Memory Training by Chinese Classics Recitation on Individuals With Subjective Cognitive Decline

China Medical University Hospital1 site in 1 country60 target enrollmentStarted: August 1, 2026Last updated:
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Not yet recruiting
Enrollment
60
Locations
1
Primary Endpoint
Change in task-related brain activation measured by functional MRI

Study Overview

Brief Summary

Subjective cognitive decline (SCD) is considered a preclinical condition associated with an increased risk of dementia and Alzheimer's disease. Effective early behavioral interventions remain limited, and the neurobiological mechanisms underlying cognitive training effects are not fully understood, particularly in culturally specific educational contexts.

This randomized, assessor-blinded, controlled clinical trial will enroll 60 individuals with SCD to evaluate the effects of a six-month structured Chinese Classics recitation training program. Participants will be randomly assigned to either an intervention group or a non-active control group. Assessments will be conducted at baseline, immediately post-intervention, and during annual follow-up.

Multimodal evaluations will include neuropsychological testing, functional magnetic resonance imaging (fMRI), electroencephalography (EEG), blood biomarker profiling, gut microbiota analysis, and fecal metabolomics. The study aims to examine clinical outcomes and explore potential neurobiological and systemic correlates associated with culturally adapted cognitive training.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Single (Outcomes Assessor)

Eligibility Criteria

Ages
60 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Age ≥ 60 years old
  • At least two "yes" responses to the following questions are required:
  • Forgetting where things are placed?
  • Unable to recall the names of good friends?
  • Unable to follow and recall conversation?
  • Subjective memory problems?
  • Consider own memory to be worse than others of a similar age?

Exclusion Criteria

  • Objective cognitive impairment defined as ≥ 1.5 standard deviations below standardized cognitive testing (e.g., MMSE)
  • Diagnosis of MCI
  • Clinical Dementia Rating (CDR) ≥ 0.5
  • Diagnosis of major depressive disorder
  • Beck Anxiety Inventory score ≥ 16
  • Other medical or neurological conditions that could explain cognitive decline (e.g., vascular dementia, traumatic brain injury)
  • Claustrophobia
  • Contraindications of MRI (e.g., non-MRI-compatible cardiac pacemaker or devices implanted within the past three months)

Arms & Interventions

Intervention

Experimental

Chinese Classics Recitation for six months

Intervention: Memory training by Chinese Classics recitation (Behavioral)

non-active control

No Intervention

Outcomes

Primary Outcomes

Change in task-related brain activation measured by functional MRI

Time Frame: Baseline and 6 months

Unit of measure: Whole-brain blood-oxygen-level-dependent (BOLD) signal change (%) Detail Functional magnetic resonance imaging (fMRI) will be used to evaluate changes in task-related brain activation associated with the intervention. Whole-brain blood-oxygen-level-dependent (BOLD) signals will be analyzed using voxel-wise general linear modeling to identify activation patterns during task performance compared with resting baseline. First-level analyses will generate subject-specific contrast maps reflecting task-related neural activation. Group-level random-effects analyses will then be conducted to compare activation patterns between study groups and across time points. Statistical significance will be determined using a voxel-level threshold corrected for multiple comparisons using the false discovery rate (FDR). Effect sizes extracted from significant brain regions will be used for group-level comparisons.

Secondary Outcomes

  • Resting-state electroencephalogram (EEG) spectral activity(Baseline and 6 months)
  • Global Cognitive Function - MMSE(Baseline and 6 months)
  • Global Cognitive Function - MoCA(Baseline and 6 months)
  • Verbal Episodic Memory - RAVLT(Baseline and 6 months)
  • Executive Function - Stroop Test(Baseline and 6 months)
  • Working Memory - Digit Span(Baseline and 6 months)
  • Language Function - Boston Naming Test(Baseline and 6 months)
  • Dementia Severity - CDR(Baseline and 6 months)
  • Vascular Cognitive Risk - Hachinski Score(Baseline)
  • Depressive Symptoms - GDS(Baseline and 6 months)
  • Anxiety Symptoms - BAI(Baseline and 6 months)
  • Cognitive Reserve - CRI-q(Baseline)
  • APOE genotype distribution(Baseline)
  • Circulating inflammatory and stress biomarkers (IL-6, TNF-α, hsCRP, and cortisol)(Baseline and 6 months)
  • Gut microbiota diversity (Shannon index)(Baseline and 6 months)
  • Gut microbiota taxonomic composition(Baseline and 6 months)
  • Fecal metabolomic profiles related to the gut-brain axis(Baseline and 6 months)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Sheng-Ta Tsai

Principal Investigator

China Medical University Hospital

Study Sites (1)

Loading locations...

Similar Trials

Chinese Classics Recitation Training in... | Clinical Trial